# Study of MP0112 Intravitreal Injection in Patients With Diabetic Macular Edema

> **NCT01042678** · PHASE1 · TERMINATED · sponsor: **Allergan** · enrollment: 18 (actual)

## Conditions studied

- Diabetic Macular Edema

## Interventions

- **BIOLOGICAL:** MP0112

## Key facts

- **NCT ID:** NCT01042678
- **Lead sponsor:** Allergan
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2010-02
- **Primary completion:** 2010-12
- **Final completion:** 2010-12
- **Target enrollment:** 18 (ACTUAL)
- **Why stopped:** The study was terminated due to a company decision.
- **Last updated:** 2014-05-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01042678

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01042678, "Study of MP0112 Intravitreal Injection in Patients With Diabetic Macular Edema". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT01042678. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*